A007460 Stock Overview
Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Aprogen Medicines Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩1,477.00 |
| 52 Week High | ₩3,185.00 |
| 52 Week Low | ₩701.00 |
| Beta | 0.98 |
| 1 Month Change | 2.93% |
| 3 Month Change | 61.95% |
| 1 Year Change | 15.66% |
| 3 Year Change | -76.50% |
| 5 Year Change | -87.16% |
| Change since IPO | -99.73% |
Recent News & Updates
Shareholder Returns
| A007460 | KR Machinery | KR Market | |
|---|---|---|---|
| 7D | 2.4% | 3.6% | 2.2% |
| 1Y | 15.7% | 11.5% | 5.4% |
Return vs Industry: A007460 exceeded the KR Machinery industry which returned 11.5% over the past year.
Return vs Market: A007460 exceeded the KR Market which returned 5.4% over the past year.
Price Volatility
| A007460 volatility | |
|---|---|
| A007460 Average Weekly Movement | 16.6% |
| Machinery Industry Average Movement | 5.5% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.7% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A007460's share price has been volatile over the past 3 months.
Volatility Over Time: A007460's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1971 | 283 | Ki-Cheol Lim | www.aprogen-kic.com |
Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foamglas, a cellular glass insulation product; and fireproof insulation works in the POSCO furnaces and boilers.
Aprogen Medicines Inc. Fundamentals Summary
| A007460 fundamental statistics | |
|---|---|
| Market cap | ₩360.50b |
| Earnings (TTM) | -₩55.62b |
| Revenue (TTM) | ₩150.58b |
2.4x
P/S Ratio-6.5x
P/E RatioIs A007460 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A007460 income statement (TTM) | |
|---|---|
| Revenue | ₩150.58b |
| Cost of Revenue | ₩116.38b |
| Gross Profit | ₩34.20b |
| Other Expenses | ₩89.82b |
| Earnings | -₩55.62b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -227.87 |
| Gross Margin | 22.71% |
| Net Profit Margin | -36.94% |
| Debt/Equity Ratio | 29.6% |
How did A007460 perform over the long term?
See historical performance and comparison